Vyne Therapeutics Incis A Clinical Stage Biopharmaceutical Company Based In Bridgewaternew Jerseyfounded In 2003The Company Focuses On Developing Innovative Therapies For Immuno Inflammatory Conditionsvyne Aims To Improve Patient Lives By Addressing Unmet Needs In Treatment Through Its Unique Approach And Partnerships The Company Utilizes Its Inhibet Platform To Advance Several Pipeline Productsnotable Therapies Include Vyn201A Topical Gel Designed To Treat Various Inflammatory Diseasesand Vyn202An Oral Small Molecule Currently In Trials For Immune Mediated Inflammatory Conditionsanother Productfmx114Targets Multiple Serious Conditions Such As Rheumatoid Arthritis And Ulcerative Colitis Vyne Therapeutics Is Publicly Traded On The Nasdaq Under The Ticker Symbol Vynethe Company Is Led By Ceo David Domzalski And Operates With A Small Teamemphasizing Collaboration In Its Research And Development Efforts
No conferences found for this company.
| Company Name | Foamix Pharmaceuticals Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
